164 results on '"Jessen, F"'
Search Results
2. Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force
3. Gaussian Process-based prediction of memory performance and biomarker status in ageing and Alzheimer’s disease—A systematic model evaluation
4. Characteristics of Adults Hospitalized for a Major Depressive Disorder: Results from the Multicenter OASIS-D Study
5. Editorial: Lecanemab: Appropriate Use Recommendations – A Commentary from a European Perspective
6. Erfordernisse an Gesundheitsinformationen und Patient*innenleitlinien aus Sicht von Betroffenen mit psychischer Erkrankung und Angehörigen. Eine qualitative Untersuchung.
7. What Matters to Patients with Alzheimer’s Disease and Their Care Partners? Implications for Understanding the Value of Future Interventions
8. P.0095 Outcome Associated with Suicidality in Inpatients with Symptoms of depression (OASIS-D): Design of a study assessing usual care outcomes
9. Collective self-trapping of atoms in a cavity
10. Dietary patterns are related to cognitive functioning in elderly enriched with individuals at increased risk for Alzheimer’s disease
11. Amyloid-related changes of basal forebrain volume and precuneus functional connectivity in Subjective Cognitive Decline patients
12. TARGETING LIFESTYLE BEHAVIOR TO IMPROVE BRAIN HEALTH: USER-EXPERIENCES OF AN ONLINE PROGRAM FOR INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE
13. Characterization of Cerebellar Atrophy and Resting State Functional Connectivity Patterns in Sporadic Adult-Onset Ataxia of Unknown Etiology (SAOA)
14. Regional susceptibility of the default mode network is associated with clinical phenotypes of Alzheimer's disease
15. Level of education modulates the impact of tau-pathology on neuronal function
16. One stop shop: Flortaucipir PET pattern predicts amyloid positivity in neurodegenerative diseases
17. HEALTH LITERACY IN INDIVIDUALS AT RISK FOR ALZHEIMER’S DEMENTIA: A SYSTEMATIC REVIEW
18. Bedeutung molekularer Bildgebung (PET) in der Diagnostik von Demenzerkrankungen
19. Probandenverfügung in der Arzneimittelforschung
20. THE ROLE OF SUBJECTIVE COGNITIVE CONCERN IN AGING
21. EP 17. Preserved frontoparietal brain morphology correlates with beneficial response to deep brain stimulation of the Nucleus basalis of Meynert in patients with Alzheimer’s disease
22. Leitliniengerechte stationäre psychiatrisch-psychotherapeutische Behandlung psychischer und Verhaltenssymptome bei Demenz
23. Klinische Phänomenologie der Autoimmunenzephalitiden
24. Eine inakzeptable Studie
25. Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
26. Kognitive Verhaltenstherapie und Assertive Community Treatment reduzieren die Anzahl stationärer Tage und verlängern die Zeit bis zu einer stationären Aufnahme bei schweren psychotischen Störungen
27. EFFECTS OF THE VACCINE VANUTIDE CRIDIFICAR WITH QS-21 ADJUVANT ON IMMUNOGENICITY
28. Effects of deep brain stimulation on prepulse inhibition in obsessive-compulsive disorder
29. Präklinische Phase der Alzheimer-Krankheit und der spinozerebellären Ataxien
30. CCL17-deficiency alters myeloid cell-responses and prevents cognitive decline in APP/PS1-mice
31. Medikamentöse Behandlung der Depression im Alter – Empfehlungen aus Internationalen Leitlinien und aktueller Literatur
32. Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
33. Prädiktion der Alzheimer-Demenz
34. Incident subjective memory complaints and the risk of subsequent dementia
35. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk
36. Angebote zur Früherkennung von Psychosen und bipolaren Störungen in Deutschland
37. Therapie von Demenzerkrankungen
38. „Mild neurocognitive disorder“ – eine Erkrankung? Pro
39. Predictors of hippocampal atrophy in critically ill patients
40. Trapping of ultracold atoms in a 3He/4He dilution refrigerator
41. Prädiktion der Alzheimer-Demenz
42. Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene–environment interaction for the risk of dementia and Alzheimer's disease dementia
43. Predictors of costs in dementia in a longitudinal perspective
44. Krankheitsmodifizierende Behandlungen
45. Subjektive und objektive kognitive Störung im Prädemenzstadium der Alzheimer-Krankheit
46. Naturally occurring -synuclein autoantibody levels are lower in patients with Parkinson disease
47. Mrp14 Deficiency Ameliorates Amyloid Burden by Increasing Microglial Phagocytosis and Modulation of Amyloid Precursor Protein Processing
48. Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment
49. Detrimental adsorbate fields in experiments with cold Rydberg gases near surfaces
50. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.